Integrating Mental Health Into a HIV Clinic to Improve Outcomes Among Tanzanian Youth

October 6, 2022 updated by: Duke University
The purpose of this study is to evaluate if a group-based mental health intervention called Sauti ya Vijana (The Voice of Youth) designed to address mental health challenges faced by adolescents in Tanzania is acceptable and feasible and if it improves mental health, antiretroviral therapy (ART) adherence, and virologic outcomes among HIV-positive adolescents as compared to youth receiving treatment as usual. Mental health intervention sessions will take place three times a month for approximately four months in groups of eight to ten youth based on age and sex. Caregivers will attend two sessions to support the youth and provide the guardian perspective on caring for HIV-positive adolescents. The investigator hypothesizes the mental health intervention will be acceptable, feasible, and will improve mental health and ART adherence among participating youth and this improvement will be sustained over time.

Study Overview

Detailed Description

The study will enroll up to approximately 130 participants from the established Kilimanjaro Christian Medical Centre and Mawenzi Saturday Teen Clinics. Participants will be assigned to approximately eight to ten persons per group, based on age and sex. Groups will be matched in pairs as closely as possible (ex. two groups of females 12-16 years of age) and assigned to Wave 1, 2, or 3. Randomization will occur on the individual level and will occur just before the start of mental health intervention for each wave. Individuals will be randomized at this time point to reduce potential drop out of those with delayed start (Wave 2/3). Randomization will occur by a coin flip for two individuals based on alphabetical order: heads will be intervention group (I) and tails the standard of care group (SOC).

This feasibility study is longitudinal with up to 24 month follow-up after intervention. Feasibility measures from lay counselors will be monitored weekly. Outcome measures will be obtained by blinded interviewers using a structured survey to inquire about mental health symptoms, self-report adherence, obtain an ART drug concentration level from a hair sample, and HIV-1 viral load from a blood sample and will be collected by the same research assistants at five to six potential time points: 1) baseline, 2) pre-intervention, 3) post-intervention, 4) 6-months post-intervention, 5) 12-months post-intervention and 6) 24-months post-intervention.

Study Type

Interventional

Enrollment (Actual)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Moshi, Tanzania
        • Kilimanjaro Christian Medical Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 24 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Youth between the ages of 12 and 24 years of age, attending the Teen Club HIV clinic at Kilimanjaro Christian Medical Centre (KCMC) and/or Mawenzi Hospital and receiving ART
  • if > or =l to 18 years, able to understand the project and provide written, informed consent
  • if < 18 years, a parent or guardian must provide written permission and participant must be able to assent
  • all adolescents must also commit to attending 10 weekly CBT (SYV) sessions and 2 individual sessions.

Exclusion Criteria:

  • Active psychosis, developmental delay, or cognitive disability that precludes active participation in consent process, intervention, and assessment interviews.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mental Health Intervention
This arm was designed based on mental health needs of HIV-infected youth in Tanzania. It incorporates principles of cognitive behavioral therapy, interpersonal psychotherapy, and motivational interviewing built into 10 group sessions, approximately 90 minutes each (2 sessions with caregiver participation) and 2 individual sessions. Groups are age and gender matched and facilitated by lay counselors with a mix of lived experience and prior mental health research experience.
Includes a standard format of greetings, review of last session content, homework discussion, new topic, assigning homework and ends with a fun activity, relaxation or game. First session is a joint session with youth and caregivers. Topics include common stresses and worries experienced by HIV+ youth; relaxation and coping techniques; cognitive behavioral triangle; story of finding out HIV status and if willing, to discuss this in an individual session, peer group session, and with caregiver; identify circles of support; discuss stigma and how to disclose HIV status to others; consider values, hopes and dreams for the future, and how to use this information to live positively with HIV. ART adherence is woven into case examples and discussions.
Active Comparator: Standard of Care
This arm includes standard medical care and adherence counseling with routine education prior to the start of the HIV youth clinic from which participants are recruited.
Standard of Care includes enhanced ART adherence based on clinic protocols and monthly HIV teaching sessions prior to adolescent clinic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant attendance
Time Frame: weekly for 16 weeks during each intervention wave (over 2 years)
Measure the percentage of participants who complete all intervention sessions and ability to interview participants for outcome measures over time.
weekly for 16 weeks during each intervention wave (over 2 years)
Caregiver participation as measured by questionnaire
Time Frame: during 2 caregiver sessions
Record willingness of caregivers to participate (if unwilling, why not) and attendance.
during 2 caregiver sessions
Caregiver participation as measured by attendance sheet
Time Frame: during 2 caregiver sessions
during 2 caregiver sessions
Fidelity as measured by weekly supervisor meeting
Time Frame: weekly for 16 weeks during the intervention wave (over 2 years)
weekly for 16 weeks during the intervention wave (over 2 years)
Fidelity as measured by fidelity checklists
Time Frame: weekly for 16 weeks during the intervention wave (over 2 years)
weekly for 16 weeks during the intervention wave (over 2 years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mental Health
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare the change in standard deviation of mental health symptoms on the PHQ-9, between the intervention group versus SOC.
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Change in Mental Health
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare the change in standard deviation of mental health symptoms on the SDQ, between the intervention group versus SOC.
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Change in Mental Health
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare the change in standard deviation of mental health symptoms on the UCLA PTSD-RI, between the intervention group versus SOC.
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Change in ART adherence
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare the change in self-report adherence between the intervention group versus SOC.
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Change in virologic outcomes
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Describe the proportion of youth with viral suppression (HIV-1 RNA < 400 copies/ml) in the intervention group and SOC.
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare method of adherence measurement
Time Frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare self-report ART adherence with drug level concentration of hair samples.
pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Change in mental health (individual)
Time Frame: baseline to post-intervention, 6-, 12-,18- and 24-months
Compare the change in standard deviation of mental health symptoms on the PHQ-9, SDQ, UCLA PTSD-RI at the individual level.
baseline to post-intervention, 6-, 12-,18- and 24-months
Change in adherence (individual)
Time Frame: baseline to post-intervention, 6-, 12-, and 24-months
Compare the change in self-reported adherence and antiretroviral drug concentration in hair.
baseline to post-intervention, 6-, 12-, and 24-months
Change in HIV viral load (individual)
Time Frame: baseline to post-intervention, 6-, 12-, and 24-months
Compare the change in HIV viral load.
baseline to post-intervention, 6-, 12-, and 24-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Dorothy E Dow, MD, MSc-GH, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2016

Primary Completion (Actual)

August 28, 2020

Study Completion (Actual)

August 28, 2020

Study Registration Dates

First Submitted

August 9, 2016

First Submitted That Met QC Criteria

August 30, 2016

First Posted (Estimate)

September 5, 2016

Study Record Updates

Last Update Posted (Actual)

October 7, 2022

Last Update Submitted That Met QC Criteria

October 6, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00069892

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV

Clinical Trials on Mental Health Intervention

Subscribe